Re-Writing the Rules for Biotherapeutic Discovery
RubrYc Therapeutics is a biotechnology company that integrates chemistry and computation to discover and develop antibody-based drugs with unprecedented epitope selectivity.
RubrYc Therapeutics is a biotechnology company that integrates chemistry and computation to discover and develop antibody-based drugs with unprecedented epitope selectivity.